DomaniCell

By Cord Blood Advisor on June 28th, 2007

DomaniCell

PHONE: 201-883-5308

OFFICE: Hackensack, NJ

STORAGE: Progenitor Cell Therapy, Hackensack, NJ

COMMENT: DomaniCell LLC is a wholly-owned subsidiary of Progenitor Cell Therapy LLC. Their business concept is to market “turn-key” Cord Blood banking to birthing hospitals.

SERVICES & DISCOUNT OPTIONS:

DomaniCell does not market Cord Blood banking directly to parents. To enroll, you or your doctor must use their Hospital Locator to find a DomaniCell Partner Hospital and you must deliver at that hospital.
DomaniCell partner hospitals are “invested” in the program, which means they receive a cut of the profits.
Cord Blood collections are processed at the laboratory of Progenitor Cell Therapy. The transplant quota are cord blood units released for transplants through public registries.
The laboratory processing uses sedimentation with hetastarch to separate MonoNuclear Cells from cord blood. Bags are used for both the blood collection and the final storage of the processed cells.
Progenitor Cell Therapy has FACT Accreditation for cellular therapy products, but they do not yet have FACT/Netcord Accreditation for cord blood processing.
Progenitor Cell Therapy laboratory follows cGMP (ie: cellular GMP) standards, which are above FDA requirements for cord blood processing.
Domanicell contract includes courier transport, usually by AirNet.
DomaniCell pricing varies from hospital to hospital.
Payment plans are always available.

ADDITIONAL information: Progenitor Cell Therapy LLC was founded in 1997 by Andrew L. Pecora, M.D., and Robert A. Preti, Ph.D. Dr. Pecora performed the first adult transplant of expanded cord blood. Dr. Preti has been the Scientific and Laboratory Director of Hackensack University Medical Center (HUMC), located in Hackensack, New Jersey. Progenitor Cell Therapy acquired HUMC in March 1999 and upgraded it to a cGMP compliant facility which is experienced in all forms of Stem Cell engineering. The CEO of DomaniCell is Dennis Fallen.